Esperion Grants Stock Options and RSUs to New Employees Under NASDAQ Listing Rule 5635(c)(4)

Esperion Therapeutics granted three new employees non-qualified stock options to purchase 380,000 shares of common stock and 435,536 restricted stock units under its 2017 Inducement Equity Incentive Plan. The options have an exercise price of $3.79 per share and will vest in 12 equal quarterly installments, while the RSUs will vest as to 25% on the one-year anniversary of the vesting commencement date and the remaining 75% in 12 equal quarterly installments. The grants were made to attract new employees.